Saima Sharif, MD
Medical Oncology · Iowa City, IANPI 1548258940
Payments from drug & device makers
What this record shows
This record is dominated by education: $122 of the $122 with a category attached, or 100.0%. That places this record below the midpoint for medical oncology clinicians in IA, where the typical reported total is $879.
Across 2 payments — averaging $60.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$68
- Genentech, Inc.$53
Across 38 payments — averaging $18,441 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$436K
- GSK$90K
- Mirati Therapeutics, Inc.$74K
- Sanofi US Services Inc.$51K
- Seagen Inc.$21K
- Novartis$16K
- plus $13K from 2 others
What the payments were for
- Education$122100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $68 |
| Genentech, Inc. | 1 | $53 |
How this compares
$122 in reported general payments places this provider in the 25th percentile of 47 medical oncology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LonsurfTrifluridine/Tipiracil Hcl | 16 | $204,121 |
| XareltoRivaroxaban | 15 | $9,101 |
| EliquisApixaban | 12 | $6,791 |
| Dexamethasone | 96 | $428 |
| LoperamideLoperamide Hcl | 21 | $271 |
| Prochlorperazine Maleate | 36 | $230 |
| Gabapentin | 16 | $230 |
| Ondansetron Hcl | 33 | $205 |
| Famotidine | 19 | $127 |
| Levothyroxine Sodium | 16 | $80 |
| Omeprazole | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Iowa City
- Jun ZhangIowa City$377K
- John RiethIowa City$11K
- Mark BurkardIowa City$10K
- Fernando Maciel BarbosaIowa City$3K
- Gustavo Fernandes Godoy AlmeidaIowa City$2K
- Margaret ByrneIowa City$1K
- Naomi FeiIowa City$1K
- Susan RoederIowa City$47
- Margarida SilvermanIowa City$0
- Tara GraffClive$702K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.